Risankizumab (Synonyms: Risankizumab rzaa; BI 655066) |
Catalog No.GC69818 |
Risankizumab (BI 655066) is a humanized IgG monoclonal antibody that targets the IL-23 p19 subunit (Kd <10 pM) and can inhibit IL-17 production induced by human IL-23 in mouse splenocytes (IC50 = 2 pM). Risankizumab can be used to study immune and inflammatory diseases such as psoriasis, psoriatic arthritis, generalized pustular psoriasis, and erythrodermic psoriasis.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1612838-76-2
Sample solution is provided at 25 µL, 10mM.
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *